Press Release

Institut Pasteur Korea Launched a Network Council for Collecting Infectious Disease Research Resources

2024-11-25
Institut Pasteur Korea Launched a Network Council
for Collecting Infectious Disease Research Resources

- Collaboration system established with 9 institutions, including university hospitals,
for collecting infectious disease specimens and pathogen resources-
-Distribution and provision of research resources to academia, industry, and research institutes,
contributing to basic infectious disease research.


 
Institut Pasteur Korea (IPK) announced the launch of a domestic network for collecting infectious disease research resources on the 21st.
The launch ceremony for the network council was held on November 19th at the BIZHUB Seoul Center in Jung-gu, Seoul, where IPK and other participating institutions discussed future plans and strategies. 



IPK operates the Global Infectious Disease Specimen Bank (GISB) and the Novel and Variant Pathogen Resource Bank (NVPRB) to provide research resources that prepare for and respond to emerging infectious diseases while promoting basic research. With the establishment of this network, IPK plans to strengthen collaborative systems with medical institutions and expand the collection of patient specimens and pathogens from infectious disease cases in Korea.

The network consists of 10 participating institutions, including IPK, Kangdong Sacred Heart Hospital, Konkuk University School of Medicine, Kyungpook National University Hospital, Korea University Guro Hospital, National Medical Center, Hallym University Dongtan Sacred Heart Hospital, Jeonbuk National University Hospital, Chosun University Hospital, and the Korea Biotechnology Research and Innovation Association (K-BIORIA).

The participating institutions will collect infectious disease resources following the Bioethics and Safety Act, the Pathogen Resource Management Act, and guidelines provided by global organizations like the World Health Organization (WHO) and Korea Disease Control and Prevention Agency (KDCA). In particular, if an emerging infectious disease (Disease X) occurs, the network will actively collect and provide the related pathogens and patient specimens, contributing to proactive infectious disease responses.

Especially, the network is expected to play a proactive role in responding to emerging infectious diseases, such as Disease X, by actively collecting and providing specimens and pathogens during outbreaks.

Sung Key Jang, CEO of IPK, said, “We will collaborate with medical institutions to accelerate the development of diagnostic tools, vaccines, and treatments for infectious diseases and build a sustainable domestic and international resource collection network.”

Additionally, IPK has previously signed MOUs with medical institutions in Côte d’Ivoire, Ghana, and Uganda to secure and collect human resources overseas.